Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A3HF
|
||||
Former ID |
DIB009758
|
||||
Drug Name |
VE-16084
|
||||
Synonyms |
ICE inhibitors, Sanofi Winthrop; VE-16084; WIN-67694
|
||||
Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Terminated | [534169] | ||
Company |
Sterling Winthrop Products Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C(=O)(N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC(=O)c1c(Cl)cc<br />cc1Cl)C)[C@@H](NC(=O)OCc1ccccc1)C(C)C
|
||||
CAS Number |
CAS 151594-01-3
|
||||
Target and Pathway | |||||
Target(s) | Interleukin-1 beta convertase | Target Info | Inhibitor | [534169] | |
Pathway Interaction Database | IL1-mediated signaling events | ||||
Direct p53 effectors | |||||
IFN-gamma pathway | |||||
Cellular roles of Anthrax toxin | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.